Antipsychotic Prior Authorization Form PDF Details

There is a new antipsychotic prior authorization form that pharmacies and prescribers will need to use for all outpatient prescriptions of antipsychotics. The form went into effect on January 1, 2017, and is required for all Medicaid members. This form will help ensure that patients are receiving the most appropriate medication for their condition. Prescriptions written before January 1, 2017, do not need to be resubmitted using the new form. For more information on the new antipsychotic prior authorization form, please visit our website or contact us by phone or email. Thank you for your continued support of our pharmacy!

QuestionAnswer
Form NameAntipsychotic Prior Authorization Form
Form Length1 pages
Fillable?No
Fillable fields0
Avg. time to fill out15 sec
Other nameshow to fill out medical prior authorization university of maryland, md antipsychotic form, maryland physician care prior auth form, maryland medicaid prior authorization form antipsychotic

Form Preview Example

Maryland Medicaid Pharmacy Program ***Complete only for patients age 10 years and older*** Phone: 1-800-932-3918 and Fax: 1-866-440-9345

Tier 2 and Non-Preferred Antipsychotic Prior Authorization Form

Prescriber Information

Prescriber Name: _______________________________________NPI #: _______________Specialty: ___________

Mailing Address: _______________________________________________________________________________

Tel: ________________ Fax: _______________ Email: ________________________________________________

Patient Information

Patient Name: _____________________________________________ Patient MA#: _________________________

Mailing Address: _______________________________________________________________________________

DOB (MM/DD/YY): _________________ Male ___ Female ___ Height (inches): _______ Weight (pounds): _______

DSM - IV - TR Diagnosis (check all that apply)

ADHD

Anti-social or Borderline Personality D/O

Asperger’s Disorder or PDDNOS Autistic Disorder

Bipolar Disorder

Conduct or Oppositional Defiant D/O Dementia

Generalized Anxiety Disorder Major Depressive Disorder Mental Retardation Obsessive Compulsive D/O Panic Disorder

Psychotic D/O Not Schizophrenia (specify):____________________

PTSD

Schizoaffective D/O

Schizophrenia

Social Phobia

Tourette’s Disorder

Other (specify):

____________________

Target Symptoms (check all target symptoms for which drug is being prescribed)

Aggression

Assault

Delusion

Depression

Hallucinations

Mania

Insomnia

Mood lability

Irritability

Self-injurious Behavior

 

Other:_________________

Antipsychotic for which authorization is being sought: (check)

Abilify®

Fanapt®

Fazaclo®

Invega®

Invega Sustenna® Latuda® olanzapine olanzapine/fluoxetine

Saphris® Seroquel XR® Zyprexa Relprevv® other: _________

Dosage Form: ________________Strength: ______________ Frequency: __________________Quantity: __________

Dosage Form: ________________ Strength: _________ ______Frequency: __________________Quantity: __________

Is requested medication a continuation of therapy from an inpatient setting?

Yes

No

Does the patient have a condition that prevents the use of the preferred medication?

Yes

No

If yes, please specify: ________________________________________________________________

Is there a drug-drug interaction between another medication and the preferred medication? Yes

If yes, please specify: ________________________________________________________________

Has the patient experienced treatment failure with other medications? Yes No

No

If yes, please list which medications the patient has tried:

Medication Name

Strength/Frequency

Duration of Treatment

Compliance

(at least 6 days/wk)

Reason for Discontinuation

I certify that the benefits of antipsychotic treatment for this patient outweigh the risks.

Prescriber Signature: ___________________________________________ Date: _________________________

(DHMH Sept. 2012)